Ottmann Susan 4
4 · Clarus Corp · Filed Jun 1, 2026
Research Summary
AI-generated summary of this filing
Clarus (CLAR) Director Susan Ottmann Receives 20,000-Share Option Award
What Happened
Susan Ottmann, a director of Clarus Corporation (CLAR), received an option award covering 20,000 shares, reported on a Form 4 for the May 28, 2026 transaction date. The filing lists the transaction as an acquisition/award (derivative) and shows $0.00 in the price column; the award is an option to purchase common stock rather than immediate share ownership.
Key Details
- Transaction date: 2026-05-28; Form 4 filed: 2026-06-01. Filing appears to report the May 28 grant in a timely manner.
- Type: Option grant (reported as "A" — award/acquisition), 20,000 underlying shares, price column $0.00.
- Vesting: Options vest 5,000 shares on each of June 30, 2026; Sept 30, 2026; Dec 31, 2026; and Mar 31, 2027 (per filing footnote).
- Shares owned following the transaction: not specified in the filing summary.
- Footnote: Grant made under Clarus’s Amended and Restated 2015 Stock Incentive Plan. No exercise price or immediate cash proceeds are reported in the Form 4 entry.
Context
This was an option award (a derivative grant) rather than a stock purchase or sale—options give the right to buy shares later if/when vested and exercised. The filing does not indicate any immediate sale or exercise; the economic interest vests over the stated schedule. Awards like this are common for directors as compensation; they are informative about compensation and potential future dilution but do not by themselves indicate immediate insider buying or selling.
Insider Transaction Report
- Award
Stock Option (right to purchase)
[F1]2026-05-28+20,000→ 20,000 totalExercise: $3.11Exp: 2036-05-28→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The option to purchase shares of Clarus Corporation's (the "Issuer") common stock, $0.0001 par value per share (the "Common Stock"), was granted under the Issuer's Amended and Restated 2015 Stock Incentive Plan. Options to purchase 5,000 shares of the Issuer's Common Stock will vest and become exercisable on each of June 30, 2026, September 30, 2026, December 31, 2026, and March 31, 2027, respectively.